To study the effects of IL-1 alpha in arthritis, we generated human IL-1 al
pha (hIL-1 alpha), Transgenic mice expressed hIL-1 alpha mRNA in various or
gans, had high serum levels of hIL-1 alpha, and developed a severe polyarth
ritic phenotype at 4 weeks of age. Not only bone marrow cells but also syno
viocytes from knee joints produced biologically active hIL-1 alpha. Synovit
is started 2 weeks after birth, and 8-week-old mice showed hyperplasia of t
he synovial lining layer, the formation of hyperplastic synovium (pannus) a
nd, ultimately, destruction of cartilage. Hyperplasia of the synovial linin
g was due to the accumulation of macrophage-like cells expressing F4/80 mol
ecules. hIL-1 alpha was widely distributed in macrophage- and fibroblast-li
ke cells of the synovial lining cells, as well as synovial fluid monocytes,
T and B cells were rare in the synovial fluid, and analysis of marker expr
ession suggests that synoviocytes were directly histolytic and did not act
as antigen-presenting cells. In the joints of these mice, we found elevated
levels of cells of the monocyte/macrophage and granulocyte lineages and of
polymorphonuclear neutrophils (PMNs), most of which expressed Gr-l, indica
ting that they were mature, tissue-degrading PMNs. Cultured synoviocytes an
d PMNs from these animals overexpress GM-CSF, suggesting that the hematopoi
etic changes induced by IL-1 and the consequent PMN activation and joint de
struction are mediated by this cytokine.